SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (278)3/8/1998 4:49:00 PM
From: Elmer Rauckman  Read Replies (2) | Respond to of 4634
 
OnSale going on sale? Bill, ONSL has a market cap in excess of 500,000,000. They run a fun auction but I see no reason for a stock without serious physical assets or a great edge commanding this kind of cap. Technically, Friday it had a failed rally and created a "shooting star" candle pattern. Perhaps they will get all of CPQ's inventory and make a killing yet they are not expected to turn a profit till Q3 99, yes late 1999. Am I missing something or is this in your category of overvalued? (disclosure, I am short ONSL)



To: Bill Wexler who wrote (278)3/8/1998 11:43:00 PM
From: BDR  Read Replies (1) | Respond to of 4634
 
Have you looked at HEPH? Their cure for AIDS and whatever else ails you is DHEA. They don't even pretend to have patent protection for this readily available, over-the-counter substance but they do have a license for a "special formulation". ZONA at least pretends to have patent protection and phentolamine still requires a prescription. Hype for DHEA may keep this one aloft for a while.

techstocks.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News